Tight coupling between cytosolic and mitochondrial metabolism is key for GSIS (glucose-stimulated insulin secretion). In the present study we examined the regulatory contribution of PDH (pyruvate dehydrogenase) kinase 1, a negative regulator of PDH, to metabolic coupling in 832/13 clonal β-cells. Knockdown of PDH kinase 1 with siRNA (small interfering RNA) reduced its mRNA (>80 %) and protein level (>40 %) after 72 h. PDH activity, glucose-stimulated cellular oxygen consumption and pyruvate-stimulated mitochondrial oxygen consumption increased 1.7-(P < 0.05), 1.6-(P < 0.05) and 1.6-fold (P < 0.05) respectively. Gas chromatography/MS revealed an altered metabolite profile upon silencing of PDH kinase 1, determined by increased levels of the tricarboxylic acid cycle intermediates malate, fumarate and α-ketoglutarate. These metabolic alterations were associated with exaggerated GSIS (5-fold compared with 3.1-fold in control cells; P < 0.01). Insulin secretion, provoked by leucine and dimethylsuccinate, which feed into the tricarboxylic acid cycle bypassing PDH, was unaffected.
INTRODUCTION
Type 2 diabetes is characterized by impaired release of insulin in response to glucose. This process, or stimulus-secretion coupling, involves at least two pathways in pancreatic β-cells: the well-defined triggering pathway, i.e. a glucose-induced rise in the ATP/ADP ratio, and the less well-characterized amplifying pathway. Both pathways are dependent on efficient coupling between cytosolic and mitochondrial metabolism [1] . The fate of pyruvate, derived from glucose through glycolysis in the cytosol, is a key event. Pyruvate enters the mitochondrial tricarboxylic acid cycle either via oxidative decarboxylation to acetyl-CoA by the PDC [PDH (pyruvate dehydrogenase) complex] or via carboxylation to oxaloacetate by PC (pyruvate carboxylase) ( Figure 1 ). Flux via lactate dehydrogenase is limited by the low activity of this enzyme in glucose-responsive pancreatic β-cells under normal oxygenated conditions [2, 3] . PC is highly expressed in pancreatic β-cells, as compared with islet non-β-cells [4] , and ∼40 % of pyruvate entry into the tricarboxylic acid cycle during glucose stimulation occurs via its carboxylation by PC [5] . Hence, PC is one of the key enzymes in glucose metabolism, and its importance for GSIS (glucose-stimulated insulin secretion) has been established by us and others [6] [7] [8] [9] [10] [11] .
The activity of the PDC is tightly regulated by substrates and products of the reaction as well as by the balance between its phosphorylation by PDH kinases and its dephosphorylation by PDPs (PDH phosphatases) [12, 13] . There are four different isoforms of PDH kinases; PDH kinase 1, 2 and 4 are expressed in pancreatic islets [13] [14] [15] [16] . The role of the PDC in GSIS is more unclear than that of PC. On one hand, neither activation of PDC by dichloroacetate and adenoviral overexpression of the catalytic subunit of PDP [17] , nor inactivation of PDC by overexpression of PDH kinase 3, an isoform of high activity not normally expressed in islets [18] , has any effect on glucose metabolism or insulin secretion. On the other hand, it has been shown that metabolite fluxes through PDC and PC are equally important for insulin secretion in 832/13 clonal β-cells [19] . Moreover, an increase in PDH kinase 4 protein expression in islets after fasting is associated with suppression of GSIS [20] , suggesting that the kinase is important in these processes. Finally, PDC activity is significantly reduced in islets from animal models of obesity and Type 2 diabetes [18, 21, 22] .
Given the unclear but potentially important role for the PDC in the control of GSIS, we decided to manipulate its activity via knockdown of PDH kinase 1. This decision was also based on our finding that expression of this regulatory kinase was increased under experimental 'glucotoxic' conditions in INS-1 832/13 clonal β-cells. This increased expression was associated with a blunted insulin response to glucose in 832/13 clonal β-cells (see Supplementary Figure S1 and Table S1 at http://www.BiochemJ.org/bj/429/bj4290205add.htm), a finding suggesting that PDH kinase 1 may be involved in the perturbation of GSIS in glucotoxicity. In the present study, following knockdown of PDH kinase 1 in 832/13 clonal β-cells using siRNA (small interfering RNA), we found that the activity of the PDC, the tricarboxylic acid cycle and the mitochondrial electron transport system were increased concomitantly with exaggerated GSIS. This indicates that entry of glucose-derived carbons via the PDC, and not only via PC, into the tricarboxylic acid cycle plays a regulatory role in GSIS.
EXPERIMENTAL

Reagents and siRNA
All chemicals were from Sigma if not stated otherwise. siRNAs were 21 nt long duplexes designed, synthesized and supplied by Ambion. Three candidate sequences against PDH kinase 1 were tested in preliminary experiments. The most efficacious sequence used in all experiments was: sense strand 5 -GCAUAAAUCCAAACUGUGAtt-3 and antisense strand 5 -UCACAGUUUGGAUUUAUGCtt-3 . As a negative control, Silencer ® Negative Control #2 from Ambion was used.
Cell culture
INS-1 832/13 β-cells were cultured in RPMI 1640 medium containing 11.1 mM D-glucose and supplemented with 10 % fetal bovine serum, 100 units/ml penicillin, 100 μg/ml streptomycin, 10 mM Hepes, 2 mM glutamine, 1 mM sodium pyruvate and 50 μM 2-mercaptoethanol, at 37
• C in a humidified atmosphere containing 95 % air and 5 % CO 2 .
Transfection
INS-1 832/13 β-cells were transfected either using the Amaxa nucleofector, according to the manufacturer's protocol, or by a mixture of DharmaFECT ® 1 (Dharmacon) and the respective siRNA. In the Amaxa procedure, 3 × 10 6 cells were resuspended in 100 μl of nucleofector solution V, containing 500 nM siRNA to PDH kinase 1 or negative control, and nucleofected with program T-27. Thereafter, cells were seeded in 24-or 12-well plates and cultured for 72 h with 11.1 mM glucose before any of the experiments were performed. When Dharmafect was employed, cells were cultured for 72 h at 37
• C in a humidified atmosphere containing 95 % air and 5 % CO 2 in the presence of 35 nM siRNA (PDH kinase 1 sequence s195775) either in XF24 V7 24-well cell culture microplates (500 μl of medium) or regular 12-well cell culture plates (1 ml of medium) at 60 000 and 380 000 cells/well respectively.
Gene expression analysis/Q-PCR (quantitative PCR)
RNA was extracted using RNAeasy (Qiagen). RNA (0.5 μg) was used for cDNA synthesis with SuperScript (Invitrogen). The reaction mixture (20 μl) , with 20 ng cDNA, 10 μl of TaqMan mastermix (Applied Biosystems), 1 μl of TaqMan gene expression assay, containing 900 μM primer, and water, was run in a 7900HT Fast Real-Time System (Applied Biosystems). The Q-PCR was carried out as follows: 50
• C for 2 min, 95
• C for 10 min, 40 cycles of 95 • C for 15 s and 60
• C for 1 min. The amount of mRNA was calculated relative to the amount of HPRT (hypoxanthine-guanine phosphoribosyltransferase) mRNA in the same sample by the formula X 0 /R 0 = 2 CtR−CtX , where X 0 is the original amount of mRNA for the gene of interest, R 0 is the original amount of HPRT mRNA, C t R is the C t (cycle threshold) value for HPRT, and C t X is the C t value for the gene of interest.
Western blotting
After transfection with siRNA for PDH kinase 1 or negative control, and culture for 72 h, cells were washed with PBS and then homogenized in lysis buffer (100 mM Tris/HCl, pH 7.4, 100 mM NaCl, 2 mM EDTA, 4.5 M urea, 1 % Triton X-100, 20 μg/ml leupeptin, 10 μg/ml antipain and 1 μg/ml pepstatin). Determination of protein concentration was performed using the BCA protein kit (Pierce). Samples were mixed with standard Laemmli loading buffer and 20 μg of protein was loaded on to 10 % polyacrylamide gels. After SDS/PAGE, proteins were electroblotted on to Immunblot PVDF membranes (BioRad). Polyclonal rabbit anti-(rat PDH kinase 1) antibody (1:1500) [23] and monoclonal mouse anti-(human β 2 A-tubulin) antibody (1:500) (Santa Cruz Biotechnology) were used as primary antibodies and horseradish peroxidase-linked goat anti-rabbit IgG antibody (1:6000) (Amersham Biosciences) and goat antimouse IgG antibody (1:8000) (Amersham Biosciences) were used as secondary antibodies. Blots were developed with enhanced chemiluminescence and detection was performed using Amersham Hyperfilm ECL (Amersham Biosciences). Films were scanned using the BioRad GS-800 Calibrated Densitometer. For loading control blots were stripped with 2 % SDS, 100 mM 2-mercaptoethanol and 62.5 mM Tris/HCl, pH 6.7.
Insulin secretion
Following transfection with siRNA to PDH kinase 1 or a negative control sequence, 832/13 β-cells were seeded in 24-well plates. When assayed, cells were kept in HBSS (Hepes-balanced salt solution; 114 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.16 mM MgSO 4 , 20 mM Hepes, 2.5 mM CaCl 2 , 25.5 mM NaHCO 3 and 0.2 % BSA, pH 7.2) supplemented with 2.8 mM glucose for 2 h at 37
• C. Insulin secretion was then measured by static incubation of cells for 1 h in 1 ml of HBSS containing 2.8 or 16.7 mM glucose or 2.8 mM glucose combined with 10 mM leucine or 10 mM dimethylsuccinate. Insulin was measured by the Coat-aCount kit (DPC), which recognizes human insulin and crossreacts approx. 20 % with rat insulin; however, INS-1 832/13 cells only express human insulin [24] .
Insulin content
INS-1 832/13 β-cells were washed in PBS, 100 μl of water was added per well, and cells were scraped off and sonicated (3 s on ice at 10 % power; VirSonic 50 sonicator). Then cells were centrifuged (5 min at the maximum speed in a benchtop centrifuge) and the supernatant was diluted 10 times in acidified ethanol (87.5 ml of 95 % ethanol, 2.5 ml of 37 % HCl and 10 ml of water). Samples were stored at −20
• C until being assayed by the Coat-a-Count kit.
PDC activity
A Dipstick assay kit for PDC activity from Mitosciences was employed. Cells transfected with siRNA to PDH kinase 1 or negative control siRNA were homogenized after 72 h by passing 5 times through a 23-G syringe needle (0.6 mm) in buffer #1, provided in the kit, and pelleted by centrifugation (10 000 g, 5 min, 4
• C). A 1/10 volume of detergent, provided in the kit, was added to the samples, which were then diluted to 1 mg/ml with buffer #1. Samples were added to a 96-well plate, followed by adsorption on to dipsticks containing immobilized antibody against the PDC, and addition of the activity buffer, which contained substrates for the PDC reaction. PDC activity was determined densitometrically from the bands with the target protein-antibody complexes formed on dipsticks, using a CCD (charge-coupled device) camera (Fuji Photo Film).
Metabolite profiling
For metabolite profiling, INS-1 832/13 clonal β-cells were transfected with siRNA to PDH kinase 1 or with a control sequence using Amaxa ® as described above, and re-seeded into 6-well plates. After 72 h of culture in RPMI 1640 medium containing 11.1 mM glucose, efficient knockdown of PDH kinase 1 was confirmed by Q-PCR as described above. Then, metabolic processes were terminated, and a cocktail of four 13 C-labelled internal standards, reflecting different classes of metabolites, was added to the samples. Next, polar metabolites were extracted and derivatized for separation by GC (gas chromatography) and detected by MS as previously described with modifications [25, 26] (see the Supplementary online data for details at http://www.BiochemJ.org/bj/429/bj4290205add.htm). The metabolites were identified by MS and retention indexes by using in-house databases as well as the NIST (National Institute of Standards and Technology) library; relative differences in individual metabolite levels were determined by calculating the resolved peak areas or areas based on the specific m/z value for each identified metabolite. Differences in the metabolite profiles between PDH kinase 1-knockdown cells and control cells were determined by multivariate analysis (see the Supplementary online data for details). Additionally, the metabolite levels were compared with a Student's t test (see Supplementary Table S2 at http://www.BiochemJ.org/bj/429/bj4290205add.htm).
Oxygen consumption rate
To determine cellular and mitochondrial oxygen consumption in INS-1 832/13 clonal β-cells, a Seahorse Extracellular Flux Analyzer XF24 (Seahorse Bioscience), which measures OCR (oxygen consumption rate), was used. The instrument senses changes in oxygen content in a 7 μl volume above plated cells in XF24 V7 24-well microplates, using a fluorescence biosensor. The measurements are non-invasive and made in short and repeated intervals. For glucose-stimulated cellular oxygen consumption, an assay medium composed of 114 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.16 mM MgSO 4 , 5.1 mM NaHCO 3 , 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 2.5 mM CaCl 2 , and 0.4 % BSA (pH 7.2) supplemented with 2.8 mM glucose was used. Prior to the assay, RPMI 1640 medium was removed and replaced by 750 μl of assay medium. Cells were preincubated under these conditions for 2 h at 37
• in air with 5 % CO 2 . The experiments were designed to determine the OCR of intact cells under low (2.8 mM) and high (16.7 mM) glucose conditions [3] . Oligomycin (5 μg/ml), which binds to and inhibits the F o proton channel of the F o F 1 -ATP synthase, was employed to determine the oligomycin-independent leak OCR, L i . The mitochondrial uncoupler DNP (2,4-dinitrophenol; 40 μM) was added to determine the electron transport capacity, E i , of the ETS (electron transport system). Rotenone (1 μM) was added to block transfer of electrons from complex I to ubiquinone.
The following mitochondrial function parameters were calculated: (i) the ADP stimulation/RCI (respiratory control index), calculated as the ratio between oxygen consumption at 16.7 mM glucose [coupled OXPHOS (oxidative phosphorylation) capacity P i ] and L i at 16.7 mM glucose; (ii) the OXPHOS limitation ratio that is controlled by the phosphorylation system and calculated as the ratio between P i and E i ; and (iii) the ECR (electron transport coupling ratio), calculated as the ratio between L i and E i .
For • C in air with 5 % CO 2 . Then, assay medium A was removed and replaced with 50 μl of assay medium B with 10 μg/ml digitonin to permeabilize the cells. After 5 min at 37
• C in air with 5 % CO 2 , 700 μl of assay medium B was added. The experiments with permeabilized cells were designed to directly determine mitochondrial oxygen consumption with 7.5 mM pyruvate as substrate in the presence (P m , state 3) and absence (L m , state 4) of 400 μM ADP. DNP (40 μM) was added to determine E m , the oxygen consumption of uncoupled mitochondria in the presence of excess metabolic substrate. Then, 5 μM rotenone was added to block transfer of electrons from complex I to ubiquinone. Tests with cytochrome c addition during OCR measurements confirmed that digitonin did not cause mitochondrial damage. Mitochondrial function parameters used were: (i) ADP stimulation or RCI calculated as P m divided by L m ; (ii) OXPHOS limitation ratio calculated as P m divided by E m ; and (iii) ECR calculated as L m divided by E m .
Statistical analysis
All data are presented as means + − S.E.M. Statistical analysis was performed using paired and unpaired Student's t tests. PDC activity data, which were arbitrary, were analysed by a nonparametric Wilcoxon signed rank test. A probability level of less than 0.05 was considered significant. Figure 1 shows the main metabolic pathways through and associated with the tricarboxylic acid cycle and the key regulatory steps. PDH kinases phosphorylate the PDC, rendering it inactive, and thereby control the flux of carbons from pyruvate into the tricarboxylic acid cycle. Expression of PDH kinase 1 was selectively increased after culture of INS-1 832/13 clonal β-cells at 16.7 mM glucose for 48 h (>2-fold increase in PDH kinase 1 mRNA compared with a 0.5-fold increase in PDH kinase 2 mRNA; see Supplementary Figure S2 at http://www.BiochemJ.org/bj/429/bj4290205add.htm). As a result of the exposure to hyperglycaemia, insulin secretion was impaired (Supplementary Figure S1 ). Thus we hypothesized that enhanced expression of PDH kinase 1 might be involved in the aetiology of the impaired GSIS that occurs in response to long-term exposure of the β-cells to high glucose concentrations. This suggests that PDH kinase 1 is an important regulator of β-cell metabolism and GSIS. To address this possibility, we decided to investigate the effect of silencing PDH kinase 1 on metabolism, mitochondrial function and insulin secretion in clonal pancreatic β-cells. To this end, INS-1 832/13 clonal β-cells were treated with siRNA against PDH kinase 1. This led to a decrease in the PDH kinase 1 mRNA level by >80 %, as quantified by Q-PCR ( Figure 2A) ; accordingly, PDH kinase 1 protein expression was decreased as well (by >40 %), as shown by Western blot ( Figure 2B ).
RESULTS
Knockdown of PDH kinase 1
PDC activity after knockdown of PDH kinase 1
To confirm that knockdown of PDH kinase 1 would have the expected metabolic impact on its downstream target, we performed measurements of PDC enzyme activity. Indeed, PDC activity was significantly higher in 832/13 clonal β-cells with knocked down PDH kinase 1 compared with negative control (1.7-fold increase; P < 0.05) ( Figure 2C ).
Insulin secretion and content after knockdown of PDH kinase 1
Next, we examined the effect of knockdown of PDH kinase 1 on insulin secretion in response to glucose and two additional Figure S1) , and can most likely be attributed to the nucleofection procedure. Knockdown of PDH kinase 1 did not affect basal insulin secretion but, remarkably, insulin secretion in response to 16.7 mM glucose increased more vigorously than in negative control cells (5-fold; P < 0.01 compared with negative control cells). In contrast, insulin secretion provoked by the two other secretagogues, leucine and dimethylsuccinate (Figure 3 ), which are metabolized in mitochondria but without the requirement of PDH, was not influenced by knockdown of PDH kinase 1. In response to leucine, cells with knocked down PDH kinase 1 increased insulin secretion 4.7-fold over basal secretion at 2.8 mM glucose, whereas negative control cells responded 3.9-fold. In response to dimethylsuccinate, cells with knocked down PDH kinase 1 increased insulin secretion 3.8-fold compared with basal (2.8 mM glucose); negative control cells responded 3.3-fold. There was no significant change in insulin content of 832/13 clonal β-cells when At 72 h after siRNA transfection, 832/13 clonal β-cells were stimulated with 2.8 mM glucose (Glc), 16.7 mM glucose, or 2.8 mM glucose combined with 10 mM leucine (Leucine) or 10 mM dimethylsuccinate (Dimethylsuccinate) respectively, over 1 h. Values are means + − S.E.M. for 15 independent experiments for GSIS and eight independent experiments for leucine and dimethylsuccinate (open bars, negative control siRNA; filled bars, PDH kinase 1 siRNA). **P < 0.01.
PDH kinase 1 had been knocked down compared with negative control cells (616.6 + − 214.1 compared with 470.7 + − 192.7 ng insulin/mg protein; n = 5).
Metabolite profiling in 832/13 clonal β-cells
We hypothesized that knockdown of PDH kinase 1 would relieve inhibition of PDC, leading to increased decarboxylation of pyruvate to acetyl-CoA and, potentially, increased funnelling of glucose-derived carbons into the tricarboxylic acid cycle. This would potentially change the levels of the tricarboxylic acid cycle intermediates and/or alter the flux through the tricarboxylic acid cycle. Exit of metabolites from the tricarboxylic acid cycle (cataplerosis) could also serve as coupling signals in the amplifying pathway of insulin secretion. To address the former possibility, we undertook a comprehensive profiling of polar metabolites extracted from 832/13 clonal β-cells, using GC/MS. In this approach, 380 resolved components (corresponding to putative derivatized metabolites) could be distinguished and relatively quantified 72 h after treatment of cells with siRNA to PDH kinase 1 or a control sequence. To this end, we identified 80 out of the 380 putative metabolites, comprising most glycolytic and tricarboxylic acid cycle intermediates, several amino acids and a number of fatty acids (see Supplementary  Table S2 ). Employing multivariate analysis, i.e. PCA (principal component analysis) and OPLS-DA (orthogonal partial least squares discriminate analysis) [27] , we found that the metabolite profile of cells where PDH kinase 1 had been knocked down was significantly different from that of the control cells ( Figure 4A ). Interestingly, we found that the tricarboxylic acid cycle intermediates malate, fumarate and α-ketoglutarate were the strongest determinants of the clustering in the statistical model and, hence, the differential nature of the metabolite profile upon the knockdown of PDH kinase 1 ( Figure 4B and Supplementary Table S2 ). This could be interpreted as a reflection of increased activity in the tricarboxylic acid cycle and, possibly also in mitochondrial metabolite shuttles. Importantly, malate is an important component of cycles from citrate or oxaloacetate to pyruvate, and is required for generation of NADPH when malate is oxidized to pyruvate by malic enzyme. Also, the level of glycerol- The levels in control cells are set to 100 %; comparisons were made using the Student's t test. *P < 0.05; **P < 0.01; ***P < 0.001. a-KG, α-ketoglutarate; Fum, fumarate; Mal, malate; β-HB, β-hydroxybutyrate; Gly 3P, glycerol-3-phosphate.
3-phosphate was significantly increased. This metabolite is part of the glycerolphosphate shuttle, which is required for the exchange of reducing equivalents between glycolysis and the tricarboxylic acid cycle, and which has been shown to play an important role in β-cell stimulus-secretion coupling [28] . Interestingly, the level of β-hydroxybutyrate, a ketone body, was reduced in cells with knocked down PDH kinase 1. This could be interpreted as increased formation of citrate from the condensation of acetylCoA (increasingly provided by PDC-catalysed formation from pyruvate) and oxaloacetate, thereby depleting acetyl-CoA as a precursor of β-hydroxybutyrate.
Oxygen consumption
Having established that activity in the tricarboxylic acid cycle was increased, as evident from increases in levels of critical intermediates, we asked whether such increases would affect OXPHOS and therefore ATP synthesis. The observed glucosestimulated increase in tricarboxylic acid cycle activity should generate more of the reducing equivalents NADH and FADH 2 , donating electrons to the mitochondrial ETS. This in turn should increase the reduction of O 2 by cytochrome c oxidase (complex IV) and generate the electrochemical potential necessary to boost OXPHOS. Thus, as complex IV activity is responsible for more than 90 % of total cellular oxygen consumption [29] , measurements of cellular and even more so mitochondrial OCRs were used to examine metabolite-stimulated alterations of mitochondrial OXPHOS. Indirectly, these measurements reflected metabolic activity of mitochondria. In pancreatic β-cells, this is highly relevant because rises in the ATP/ADP ratio and metabolic intermediate levels control insulin secretion, i.e. stimulus-secretion coupling.
OCR measurements using the Seahorse XF24 showed that intact glucose-responsive INS-1 832/13 clonal β-cells progressively and significantly increased their OCR by an average of 2.33 + − 0.13 nmol O 2 /min per mg of protein in response to 16.7 mM glucose (P i ) compared with the basal OCR at 2.8 mM glucose ( Figure 5A ). When PDH kinase 1 was knocked down in the 832/13 β-cells, the glucose-induced increase in the OCR was significantly exaggerated, reaching 3.08 + − 0.30 nmol O 2 /min per mg of protein (P < 0.05). This effect of PDH kinase 1 knockdown coincided with: (i) an increased ADP-stimulation driven by the proton gradient dissipation through the ATP synthase. This was calculated as the difference between P i and L i (3.66 + − 0.20 in control cells compared with 4.27 + − 0.19 nmol O 2 /min per mg of protein in PDH kinase 1 knockdown cells; P < 0.05) and (ii) an increased L i and E i ( Figure 5A ). In contrast, the functional indicators RCI, ECR and the OXPHOS limitation ratio showed no significant change (see Supplementary Table S3 at http://www.BiochemJ.org/bj/429/bj4290205add.htm).
Given that PDH kinase 1 knockdown altered pyruvate metabolism, we next directly measured pyruvate-stimulated mitochondrial oxygen consumption in digitonin-permeabilized 832/13 β-cells. We found that, in comparison with control cells, PDH kinase 1 knockdown increased the P m (state 3), L m (state 4) and E m (DNP) as well as the rotenone-independent OCR ( Figure 5B ). As in intact cells, PDH kinase 1 knockdown did not change RCI, the OXPHOS limitation ratio and ECR (see Supplementary Table S3 ).
The exaggeration of the coupled OXPHOS capacity in intact and permeabilized 832/13 β-cells was expected, and confirmed that there was an increased availability of reducing equivalents upon silencing of PDH kinase 1. More so, the metabolomic data on the abundance of malate, α-ketoglutarate and fumarate, together with the observed proportionally similar general increase of coupled OXPHOS capacity and electron transport capacity of the ETS indicate that PDH kinase 1 knockdown leads to increased metabolic and OXPHOS fluxes in mitochondria in response to glucose stimulation. This is likely to increase ATP generation. The results further indicate an increased potentially controlled/induced and functionally important proton conductance under non-stimulatory conditions after PDH kinase 1 knockdown as the leak OCR increase was also proportionally similar, whereas the ECR was unaltered. The observed large, but PDH kinase 1 knockdown-independent, excess capacity of the ETS in intact cells as well as mitochondria of permeabilized cells, expressed as the OXPHOS limitation rate, indicated a pronounced PDC-independent limitation of the OXPHOS capacity by the phosphorylation system (ATP synthase, adenine nucleotide translocator and phosphate transporter). Thus we conclude that in INS-1 832/13 clonal β-cells, the metabolic flux from the cytosol into mitochondria, at least through PDC, has no substantial influence on OXPHOS limitation. Nonetheless, it will be necessary to further investigate this limitation as it may potentially alter stimulus-secretion coupling through the sensitive phosphorylation state of the ATP pool in the cytoplasm.
Figure 5 Analysis of OCR upon PDH kinase 1-silencing
Analysis was performed in 832/13 clonal β-cells using a Seahorse XF 24 flux analyser. Top panel, cells were preincubated at 2.8 mM glucose for 2 h. Then OCRs were measured first at 2.8 mM glucose followed by measurements at 16.7 mM after glucose injection at time point 1. At time point 2, oligomycin, an inhibitor of ATP synthase was added; at time point 3, dinitrophenol, an uncoupler was added, followed by rotenone at time point 4, an inhibitor of complex 1 (ᮀ, negative control siRNA; , PDH kinase 1 siRNA). Lower panel, after the treatment described in the upper panel, 832/13 clonal β-cells were permeabilized and exposed to pyruvate. OCR for P m (state 3, excess ADP) and L m (state 4, ADP consumed) as well as for DNP-uncoupled mitochondria in the absence (E m , DNP) and presence of rotenone (DNP/rotenone) are given (open bars, negative control siRNA; filled bars, PDH kinase 1 siRNA). Comparisons were made by paired Student's t test due to differences between passages. *P < 0.05; **P < 0.01.
To confirm the OXPHOS-dependent increase in ATP generation, we have tried to determine differences in the ATP/ADP ratios in our experimental model using conventional biochemical techniques [7] . Although an elevation of glucose from 2.8 to 16.7 mM robustly increased the ATP/ADP ratio (primarily via reduction of ADP; results not shown), we failed to identify an exaggeration of the ATP/ADP ratio in INS-1 832/13 β-cells upon knockdown of PDH kinase 1. This could be explained by the complications arising from a potentially prevailing compartmentalized increase that would not be detected in a cellular extract. Another possibility is timing; we analysed accumulation of the nucleotides at 5 and 30 min after elevation of glucose; perhaps at another time point, a differential rise in the ATP/ADP ratio would have been apparent.
Overall, the oxygen consumption results indicate that PDH kinase 1 knockdown was not associated with functional alterations in the mitochondrial OXPHOS system. Instead, they further substantiated our initial conclusion that PDH kinase 1 knockdown leads primarily to increased metabolic flux and therefore enhanced metabolite-stimulated OXPHOS. The consequence of this will be more metabolically generated ATP.
DISCUSSION
The present study is an extension of the efforts of a number of laboratories to resolve the way fuel metabolism controls insulin secretion from the pancreatic β-cell. On a comprehensive level, our studies reinforce the concept that the precise way in which glucose-derived carbons are metabolized in the mitochondrion plays a more important role in GSIS than the overall rate of cellular glucose metabolism.
Although the majority of the previous studies concerning stimulus-secretion coupling have addressed the role of carbons entering into the mitochondrial tricarboxylic acid cycle via the PC-catalysed reaction [7, 9, 10, 19] , we have examined the role of the PDC. This initiative was prompted both by the wellknown importance of the PDC for the control of tricarboxylic acid cycle activity, and by our finding that PDH kinase 1 was up-regulated in 832/13 clonal β-cells exposed to high glucose resulting in impaired GSIS (Supplementary Figures S1 and S2) . It raised the possibility that PDH kinase 1 is part of the metabolic control of GSIS. PDH kinase 1 is one of four isoforms of PDH kinase, inactivating the PDC via phosphorylation of three serine residues on PDC E1α: Ser 264 (site 1), Ser 271 (site 2) and Ser
203
(site 3) [13, 30] . All PDH kinases can phosphorylate site 1 and site 2, whereas PDH kinase 1 uniquely phosphorylates site 3 [31] . This suggests that site 3 is of special importance in tissues where PDH kinase 1 is expressed. Indeed, PDH kinase 1 is expressed in pancreatic islets [20] and clonal β-cells (shown in the present study), heart [32] and, to a lesser extent, skeletal muscle [33] . Since reactivation of E1α requires removal of all three phosphate groups, PDH kinase 1 phosphorylation of site 3 could be particularly effective in maintaining the inactivity of the PDC. Previous studies have reported discrepant data regarding the potential roles of the PDH kinases in modulating insulin secretion [17] . Although our examination shows a clear effect on GSIS and metabolism, such effects were lacking in a previous study that employed adenoviral overexpression of PDH kinase 3 [17] , an isoform not expressed in 832/13 clonal β-cells. The discrepancy may be attributed to the differential affinity of the PDH kinases for phosphorylation sites on PDC E1α. Interestingly, although the activity of the PDH kinases is inhibited by pyruvate, that of PDH kinase 1 is the least susceptible to inhibition by this critical metabolite [23] . Thus PDH kinase 1 would be predicted to be less inactivated compared with other PDH kinase isoforms by an acceleration of glycolytic flux. The regulation of PDH kinase 1 would thus be analogous to that of glucokinase compared with hexokinase, where the former lacks product inhibition by glucose-6-phosphate, rendering it more suitable for the role as 'glucosensor' in pancreatic β-cells and hepatocytes. On a more detailed mechanistic level, knocking down PDH kinase 1 provided novel insight into the metabolic coupling of the stimulus for secretion in clonal β-cells. Setting the stage for our studies, knockdown of PDH kinase 1 decreased both PDH kinase 1 mRNA and protein levels, and promoted a significant enhancement of GSIS. Moreover, an increase in the PDC activity was observed, indicating that decreased PDH kinase 1 expression is translated to decreased PDC phosphorylation and, consequently, increased PDC activity. A PDC activitydependent increase in the import of glucose-derived carbons, i.e. from pyruvate into mitochondria and the associated enhancement of metabolic flux within mitochondria, i.e. the tricarboxylic acid cycle, are in good agreement with the PDH kinase 1 knockdown-associated increases in levels of the tricarboxylic acid cycle intermediates malate, fumarate and α-ketoglutarate. Such increases also require anaplerotic input of carbons into the tricarboxylic acid cycle, producing more oxaloacetate, which can be condensed with acetyl-CoA to form citrate and the subsequent tricarboxylic acid cycle intermediates. Anaplerotic activity in clonal β-cells is now well-established [7, 9, 10, 19] . The mechanism is further supported by our observation that insulin secretion stimulated by leucine or dimethylsuccinate, which enter the tricarboxylic acid cycle independent of PDH activity, was unaffected by knockdown of PDH kinase 1. Furthermore, glucosestimulated increases in citrate, malate and α-ketoglutarate have previously been described in INS-1 cells using biochemical analyses [6, 34] . We also know from previous studies [2, 3] that competing metabolic fluxes such as lactate formation are unlikely, since lactate dehydrogenase activity is very low in the 832/13 β-cells [3] .
In the attempt to elucidate the mechanism behind the observed enhancement of GSIS in 832/13 clonal β-cells upon knockdown of PDH kinase 1, we hypothesized that increased PDH activity would tighten the metabolic coupling between the cytosol and mitochondria; more pyruvate would be decarboxylated, forming acetyl-CoA for subsequent generation of citrate from oxaloacetate. Tightened metabolic coupling should hence increase tricarboxylic acid cycle metabolism and thus the metabolite flux-controlled mitochondrial synthesis of ATP via OXPHOS. Pyruvate cycling, which requires the action of PC, and is positively correlated with glucose responsiveness in 832/13 clonal β-cells, would be a complementing metabolic flux [9] . The exact path of this cycle was not determined, and it was assumed to exert its effects via metabolic intermediates, e.g. NADPH [35, 36] , acting downstream on exocytotic control elements [9, 37] .
GSIS via an increased ATP/ADP ratio based on metabolitestimulated OXPHOS necessitates elevated mitochondrial oxygen consumption. The proton circuit across the inner mitochondrial membrane links the reducing equivalent-dependent electron transport, oxygen consumption and ATP generation, i.e. OXPHOS. Indeed, PDH kinase 1 knockdown caused a pronounced metabolite stimulation of cellular oxygen consumption. Thus our present study clearly indicates that, in glucose-responsive 832/13 clonal β-cells, PDH kinase 1-regulated PDC activity contributes to β-cell stimulus-secretion coupling via a metabolite-driven increase in OXPHOS-based ATP production. Moreover, we could rule out any PDH kinase 1 knockdowndependent fundamental functional alterations in the OXPHOS system besides electron transport maximization in the ETS. Our data further indicate that the metabolite stimulation was based on an increased metabolic flux of cytosolic glucose-derived carbons into mitochondria via PDC, in turn increasing metabolic flux through the tricarboxylic acid cycle. This increased metabolic flux apparently increased the generation of NADH and FADH 2 , which, in turn, stimulated the activity of the mitochondrial ETS and therefore oxygen consumption. However, when ADP levels fall and the ATP/ADP ratio approaches an equilibrium, excess carbons may leave the tricarboxylic acid cycle (cataplerosis), particularly in a cell such as the β-cell, where PC activity is known to be high [5] , driving anaplerosis [9] . Such exit of metabolic intermediates has been suggested to be part of β-cell stimulussecretion coupling [36] , and is also suggested by the findings in the present study of increased levels of α-ketoglutarate, fumarate and malate.
A reduced level of β-hydroxybutyrate, as observed upon PDH kinase 1 knockdown, would be expected to occur if β-oxidation is restricted or if acetyl-CoA levels drop as a consequence of increased formation of oxaloacetate. Indeed, citrate exiting from mitochondria would lead to cytosolic production of acetyl-CoA by the reaction catalysed by citrate lyase, which in turn may be carboxylated to malonyl-CoA. Malonyl-CoA is a strong allosteric inhibitor of carnitine palmitoyl transferase 1, thus preventing flux of long-chain acyl-CoAs into the mitochondrion for subsequent β-oxidation. This presumed elevation of cytosolic long chain acylCoAs could potentially have been stimulating exocytosis [38, 39] and/or influenced proton conductance. However, the support for the role of malonyl-CoA in stimulus-secretion coupling in 832/13 clonal β-cells has not been unambiguous [40, 41] . Whether malonyl-CoA production is enhanced upon silencing of PDH kinase 1 is not known, but silencing of acetyl-CoA carboxylase 1 in 832/13 clonal β-cells and rat islets has recently been reported to suppress GSIS via inhibition of glucose rather than lipid metabolism [42] . The possibility that acetyl-CoA levels drop, indicated by reduced β-hydroxybutyrate levels, agrees with increased anaplerosis, a phenomenon that has been repeatedly shown in clonal β-cells [7, 9, 10, 19] . Anaplerosis was further indicated by the fact that levels of α-ketoglutarate, fumarate and malate rose upon silencing of PDH kinase 1.
In conclusion, we have identified a potential role for PDH kinase 1 in the regulation of glucose responsiveness in clonal β-cells. The mechanisms of this role are illustrated in Figure 6 . We suggest that maintaining low PDH kinase 1 expression, keeping the PDC in a relatively dephosphorylated and active state, plays an important role for robust GSIS in clonal β-cells. In the event that the role of PDH kinase 1 in GSIS can be confirmed as a more general mechanism for metabolic control of insulin secretion, it may prove to be a target for glucose-dependent insulinotropic drugs in treatment of failing insulin secretion in Type 2 diabetes.
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INTRODUCTION
This supplementary data describes how we identified that isoforms of PDH (pyruvate dehydrogenase) kinase were differentially regulated in 832/13 clonal β-cells upon culture at 16.7 mM glucose for 48 h. This condition was chosen as a model for a 'glucotoxic' situation in pancreatic β-cells. The model was validated functionally by analysis of insulin secretion followed by profiling of expression of metabolic enzymes. The supplement also provides more detailed information about how the metabolite profiling was conducted as well as some additional information about parameters measured in the Seahorse XF24 derived from oxygen consumption rates.
METHODS AND RESULTS
Insulin secretion and content in 832/13 β-cells cultured at low and high glucose for 48 h
To establish conditions in 832/13 clonal β-cells where metabolic regulation of insulin secretion was affected and allow identification of regulatory metabolic genes, we cultured cells for a prolonged time period (48 h) at either low (2.8 mM) or high (16.7 mM) glucose. It was predicted that exposure to high glucose concentration would induce a glucotoxic condition with impaired GSIS (glucose-stimulated insulin secretion). After 48 h culture at 2.8 mM glucose, insulin secretion increased 6.8-fold upon acute (1 h) stimulation with 16.7 mM glucose ( Figure S1 ); note that this fold-change is greater than when 832/13 clonal β-cells have been subjected to the nucleoporation procedure using Amaxa ® (compare Figure S1 with Figure 3 in the main text). Under conditions where the K ATP channels were bypassed with 35 mM KCl and 250 μM diazoxide, insulin secretion at 2.8 mM glucose increased 6-fold; a further 3-fold increase in insulin secretion occurred when the glucose was increased to 16.7 mM. Insulin secretion at basal glucose concentrations was lower (P < 0.01) when cells had been pre-cultured at high glucose. Furthermore, cells cultured for 48 h at 16.7 mM glucose increased insulin secretion by only 3.5-fold when stimulated with 16.7 mM glucose compared with 2.8 mM. Similarly, under K ATP -channelindependent conditions, insulin secretion rose only 2-fold upon stimulation with 16.7 mM glucose. Culture at high glucose concentrations decreased total cellular insulin content by approx. 80 % (594 + − 144 compared with 105 + − 50 ng of insulin/mg of protein). 
LDA (Low density array)
To screen for changes in genes for metabolic enzymes, an LDA was designed. TaqMan LDAs (Applied Biosystems) are created on a 384-well microfluidic card, which are arrayed with TaqMan gene expression assays of your own choice. We designed the card to comprise assays for 46 of the essential genes in glycolysis, the tricarboxylic acid cycle and the respiratory chain (Table S1) ; the assays were pre-designed and validated by Applied Biosystems. Four different housekeeping genes were evaluated for stable expression at high and low glucose concentrations with Q-PCR: 18S, 29S, HPRT (hypoxanthineguanine phosphoribosyltransferase) and β-actin. Expression of HPRT varied the least at different glucose concentrations, and HPRT was therefore included in the LDA. 832/13 clonal β-cells were cultured at 2.8 or 16.7 mM glucose for 48 h, and afterwards RNA and cDNA were prepared as described in the Experimental section of the main text. cDNA (50 ng) was then loaded on to each port on the microfluidic card, and the card was run on a 7900HT Fast Real-Time System. 
Gene expression analysis
In the next step, expression of the candidate metabolic genes was assessed in the designed LDA in cells pre-cultured at 2.8 mM and 16.7 mM glucose, when insulin secretion was diminished. Out of the 46 genes, six were differentially expressed following culture at 16.7 mM glucose compared with 2.8 mM glucose ( Figure S2 ). Five of them were up-regulated at high glucose and one was down-regulated. The up-regulated genes were glyceraldehyde-3-phosphate dehydrogenase (2.6-fold increase; P < 0.05), the glycolytic enzymes triosephosphate isomerase 1 (2.5-fold increase; P < 0.05) and phosphoglycerate kinase 1 (2.4-fold increase; P < 0.05), the lipogenic enzyme acetyl-CoA carboxylase (2.3-fold increase; P < 0.001) and PDH kinase 1 (2.4-fold increase; P < 0.01). PDH kinase 2, another PDH kinase isoform expressed in these cells, was down-regulated by 43 % (P < 0.01). PDH kinase 4 mRNA was not detectable. Given our objective to study the role of mitochondrial metabolism in β-cell stimulus-secretion coupling, and the potential of PDH kinase 1 to control carbon flux into the tricarboxylic acid cycle, via inhibition of pyruvate dehydrogenase, we chose PDH kinase 1 to be our target in the present paper.
Metabolite profiling by GC/MS
Sample preparation and derivatization
Cells were grown in six-well plates, washed with 2 ml of PBS and quenched and scraped off into 180 μl of cold methanol (−80
• C). Six wells were pooled for each sample and two 40 μl aliquots were removed for protein determination [using the BCA (bicuchonic acid) assay]. To the remainder was added 1 ml water, 1 ml chloroform and 8 μl of an internal standard solution containing 13 C 6 -glucose, 13 C 3 -15 N-alanine, 13 C 4 -succinic acid and 13 C 5 -alpha-ketoisovaleric acid (0.375 μg of each); samples were vortexed for 30 min, followed by centrifugation at 13 000 g for Cells were cultured for 48 h in 2.8 or 16.7 mM glucose, and gene expression was then determined in the LDA by Q-PCR. ACC, acetyl-CoA carboxylase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PGK, phosphoglycerate kinase 1; PDK1, PDH kinase 1; PDK2, PDH kinase 2; TPI, triosephosphate isomerase 1. Values are means + − S.E.M. for five independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
30 min. The water-rich top phase (1600 μl) was transferred into a new vial and vacuum centrifuged at 30
• C to dryness. Methoxyamine hydrochloride (25 μl; 20 mg/ml) in dry pyridine was added; samples were vortexed for 5 min and incubated at room temperature (20 • C) for 17 h. Then, 25 μl of N-methyl-N-trimethylsilyl trifluoroacetamide was added; samples were vortexed for 5 min and incubated at 37
• C for 30 min.
GC/MS
A 1 μl aliquot of each sample was injected splitless by an Agilent 7683B autosampler (Agilent) into an Agilent 6890N gas • C and the gas flow rate was 1 ml/min. The column temperature was held at 70
• C for 5 min followed by a 15
• C/min rise to 310 • C where it was held for 3 min. Detection was performed by EI (electron impact), TOF-MS (time-of-flight MS) (Pegasus III TOF-MS, Leco Corp.) with the transfer line at 250
• C and the ion source at 250
• C. Ionization was performed at 70 eV, and 20 spectra between 50 and 800 m/z were acquired per min. Sample preparation and analysis were performed in two different randomized orders. Retention indexes were calculated from the elution times of a homologous series of n-alkanes.
Data processing
All data were processed using the H-MCR (hierarchical multivariate curve resolution) Matlab script [1] . The resulting data matrix was normalized against the TIC (total ion count) and to a weight calculated from a PCA (principal component analysis) of the four internal standards [2] . The internal standards were subsequently removed from the data matrix. Identification of resolved peaks was performed using mass spectra library and retention index searches against the NIST (National Institute of Standards and Technology) library and in-house databases.
Multivariate statistics
All chromatographic peaks were centered and scaled to unit variance. PCA and OPLS-DA (orthogonal partial least square discriminant analysis) were performed using SIMCA-P+ 11.5 Figure S3 PCA score plot of PC4 (t4) and PC2 (t2) P, PDH kinase 1 knockdown; N, negative control samples.
Table S3 Mitochondrial function parameters
The parameters were calculated as described in the Experimental section in the main paper. ECR, electron transport coupling ratio; OXPHOS, oxidative phosphorylation; RCI, respiratory control index; siPDK1, PDH kinase 1 siRNA (small interfering RNA); siNC, negative control siRNA. 
Metabolite profiling by GC/MS
Four samples were removed from the data set due to emulsification during two-phase extraction, loss of one sample, significantly lower internal standard signals and low cell material content, resulting in a data set composed of 13 PDH kinase 1 knockdown and 13 negative controls. Initially, an unsupervised (no class information in the model) PCA model was calculated with five components and R2 = 0.73 and Q2 = 0.45. Clustering of the samples is clearly seen in the scores for PC1 and PC4, with only two samples found in the wrong clusters ( Figure S3 ). Interpretation of the PCA score plot can be performed by evaluating the loadings of the metabolites along the components in which the samples cluster. However, as the clustering is found along more than one PC, interpretation of the plot is difficult. A partial least square model was also constructed; however, the same difficulties in interpretation holds also for this plot (results not shown).
In the supervised (using class information) OPLS-DA, the first component (the predictive component) describes betweenclass separation and the following components (orthogonal components) describe within-class separation. The OPLS-DA model resulted in one predictive and two orthogonal components with the cross-validated predictive ability Q 2 (Y) = 0.55, the total explained variance R 2 (X) = 0.91, and the variance related to class separation R 2 p (X) = 0.17. No samples were mis-classified (see Figure 4A in the main text).
The metabolite differences explaining the class differences were identified by interpreting the loadings along the predictive component from the OPLS-DA model, as described previously [3] , together with the 95 % confidence intervals, calculated using jack-knifing ( Figure S4 ) [4] . Metabolites with positive loadings are up-regulated by the knockdown of PDH kinase 1, whereas those with negative loadings are down-regulated. From this plot, all insignificantly altered metabolites and metabolites that have not been identified have been removed. The unknown peaks are, nevertheless, of equal importance in the model and they may contain interesting information on the effects of the action of PDH kinase 1. Identification of these peaks using high resolution MS or other methods may reveal additional information of involved metabolic pathways. OPLS-DA has the advantage over traditional t tests that it separates within-class and between-class variations. OPLS-DA models reveal statistically significant alterations in the metabolome based on cross-validation and confidence intervals, and in addition it provides visualization of the results.
